ITIS Holdings Inc. Rescinds DTC Withdrawal
Business Editors & Health/Medical Writers
HOUSTON--(BUSINESS WIRE)--Jan. 29, 2003--ITIS Holdings Inc. (OTCBB:ITHH) announced that the directors voted today to rescind the company's prior action in making its stock non-depository eligible. "We do not want to cause our loyal stockholders any hardship," said Hunter M. A. Carr, CEO, "and the directors have voted unanimously to return to Depository Trust." The company has notified Depository Trust Corporation and Atlas Stock Transfer Corporation of the Board's decision to rescind the withdrawal from depository eligibility for its common stock.
About ITIS Holdings Inc.
ITIS Holdings Inc. operates subsidiaries that provide automated litigation support (http://www.litidex.com), and that operate specialized medicine pharmacies through PharmHouse, in addition to OnPoint Solutions, a developer of the Litidex(R) software, the RightScript(TM) software to be used in the pharmacies, and other software and hardware technologies. Subsidiary National Law Library Inc., receives royalties related to the sale of its legal databases.
Except for the historical information contained in this press release, certain statements in this release are forward-looking statements within the meaning of "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance, or achievements of ITIS Holdings Inc. and/or its subsidiary companies to be materially different from those expressed or implied by such forward-looking statements. Such factors include: general economic and business conditions; competition; success of operating initiatives; development of capital and operating costs; market conditions; advertising and promotional efforts; adverse publicity; changes in business strategy or development plans; quality of management and other personnel; and government regulations. Other risk factors are listed in the most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission.
--30--AA/ho*
CONTACT: ITIS Holdings Inc., Houston
Carol Brand, 281/600-6000 Ext. 524
carol.brand@itisinc.com
KEYWORD: TEXAS
INDUSTRY KEYWORD: MEDICAL PHARMACEUTICAL
SOURCE: ITIS Holdings Inc.
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
URL: businesswire.com
-0- Jan/29/2003 21:53 GMT
bloomberg.com. |
